Agile Therapeutics Appoints Josephine Torrente to its Board

PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Josephine Torrente has been appointed to the Company’s board of

Related Keywords

United States , Josephine Torrente , Phelps Mcnamara , Al Altomari , Corporate Governance Committee , Regulatory Affairs , Nasdaq , University Of Alabama At Birmingham , Exchange Commission , Agile Therapeutics Inc , Temple University School Of Law , Corporate Communications , Sprout Pharmaceuticals As Executive Vice , Securities Exchange , Wyeth Ayerst Research , Technology Committee , Case Western Reserve University , Corporate Governance , Chief Executive Officer , Sprout Pharmaceuticals , Executive Vice President , Temple University School , Agile Therapeutics , Looking Statement Certain , Securities Act , Securities Exchange Act , Perceptive Advisors , Annual Report , Quarterly Reports , Matt Riley Head , Investor Relations , Money , Ational ,